These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753 [TBL] [Abstract][Full Text] [Related]
6. Helping smokers quit through pharmacogenetics. Lerman C LDI Issue Brief; 2006; 11(6):1-4. PubMed ID: 16827222 [TBL] [Abstract][Full Text] [Related]
7. The genetic determinants of smoking. Batra V; Patkar AA; Berrettini WH; Weinstein SP; Leone FT Chest; 2003 May; 123(5):1730-9. PubMed ID: 12740294 [TBL] [Abstract][Full Text] [Related]
8. Interventions for smoking cessation and reduction in individuals with schizophrenia. Tsoi DT; Porwal M; Webster AC Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777 [TBL] [Abstract][Full Text] [Related]
9. Review of bupropion for smoking cessation. Richmond R; Zwar N Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907 [TBL] [Abstract][Full Text] [Related]
10. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511 [TBL] [Abstract][Full Text] [Related]
11. Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment. Russo P; Cesario A; Rutella S; Veronesi G; Spaggiari L; Galetta D; Margaritora S; Granone P; Greenberg DS Curr Med Chem; 2011; 18(1):91-112. PubMed ID: 21110812 [TBL] [Abstract][Full Text] [Related]
12. Current pharmacological treatments for nicotine dependence. George TP; O'Malley SS Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978 [TBL] [Abstract][Full Text] [Related]
13. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline. Johnson TS J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090 [TBL] [Abstract][Full Text] [Related]
14. The Role of Pharmacogenetics in Smoking. El-Boraie A; Tyndale RF Clin Pharmacol Ther; 2021 Sep; 110(3):599-606. PubMed ID: 34165800 [TBL] [Abstract][Full Text] [Related]
15. Genetics and smoking behavior. Schnoll RA; Johnson TA; Lerman C Curr Psychiatry Rep; 2007 Oct; 9(5):349-57. PubMed ID: 17915073 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. Drgon T; Johnson C; Walther D; Albino AP; Rose JE; Uhl GR Mol Med; 2009; 15(7-8):268-74. PubMed ID: 19593411 [TBL] [Abstract][Full Text] [Related]
17. Achieving tobacco cessation: current status, current problems, future possibilities. Vaszar LT; Sarinas PS; Lillington GA Respiration; 2002; 69(5):381-4. PubMed ID: 12232442 [TBL] [Abstract][Full Text] [Related]
19. [Bupropion. An antidepressant used to help smoking cessation]. Taeron C Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615 [No Abstract] [Full Text] [Related]